A remedy for biomarker addiction: back to rational anticancer drug development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,General Medicine
Link
http://www.nature.com/articles/ncponc0811.pdf
Reference8 articles.
1. Slamon DJ et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177–182
2. Druker BJ and Lydon MB (2000) Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest 105: 3–7
3. Piro LD (2004) Apoptosis, Bcl-2 antisense (oblimersen sodium), and cancer therapy. Oncology 18: 5–10
4. Wagner JA et al. (2007) Biomarkers and surrogate end points for fit-for-purpose development and regulatory evaluation of new drugs. Clin Pharmacol Ther 81: 104–107
5. Adjei AA et al. (2000) Comparison of potential markers of farnesyltransferase inhibition. Clin Cancer Res 6: 2318–2325
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer;Gynecologic Oncology;2010-03
2. Synthesis and biological evaluation of novel hydrazide based cytotoxic agents;Expert Opinion on Investigational Drugs;2009-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3